Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 22,700 shares at $3.69 ($10K) on 2022-09-19, disclosed to the SEC on 2026-01-12.
Open-market purchase of $10k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.69 | 2,700 | $10K | 100.0% |
| 2 | $0.00 | 20,000 | $0 | 0.0% |
| Total | $0.44 avg | 22,700 | $10K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |
| MAIA | BUY | 2025-11-26 | $25K | — | Filing → |